In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for ….

In what Lawrence Livermore National Lab said is “a substantial milestone for supercomputing-aided drug design,” LLNL and BridgeBio Oncology Therapeutics today announced clinical trials have begun for ….
The state of quantum is full of promise and in a constant flux, so much so that it’s hard to keep track of. In this webinar, we have Julliette Peyronnet of French ….
Cloud security is a critical consideration, there’s no denying that. From your intellectual property and software services you sell, to sensitive data on customers and users, any threat can put your reputation on the line. While public cloud resources are key enablers of business, they come with the adoption of a shared responsibility model that […]
A happy month of February to you! The big players have dominated the HPC-AI news front of late, here’s a fast (8:44) recap of recent developments, including: Microsoft Maia 200 ….
